Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Difficult Toddler Temperament – Prevalence and Associated Factors at 18-Month Follow-Up of a Birth Cohort

Bhadelia A, Barr KR, John JR, Jalaludin B, Dissanyake C, Williams K, Woolfenden S, Eapen V

Neuropsychiatric Disease and Treatment 2024, 20:967-977

Published Date: 9 May 2024

Original Research

Gender Differences in Prevalence and Associated Factors of Dyslipidemia in Initial-Treatment and Drug-Naïve Schizophrenia Patients

Deng F, Ma J

Neuropsychiatric Disease and Treatment 2024, 20:957-966

Published Date: 8 May 2024

Review

The Unmasking of Autism in South Africa and Nigeria

Adams SN

Neuropsychiatric Disease and Treatment 2024, 20:947-955

Published Date: 8 May 2024

Original Research

Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile

Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP

Neuropsychiatric Disease and Treatment 2024, 20:923-936

Published Date: 3 May 2024

Original Research

Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson’s Disease: A Cross-Sectional Study

Ouyang Q, Xu L, Zhang Y, Huang L, Li L, Yu M

Neuropsychiatric Disease and Treatment 2024, 20:913-921

Published Date: 30 April 2024